Eslicarbazepine acetate: an update on efficacy and safety in epilepsy

A Verrotti, G Loiacono, A Rossi, G Zaccara - Epilepsy research, 2014 - Elsevier
Epilepsy is a common neurological disorder. Despite a broad range of commonly used
antiepileptic drugs, approximately 30% of patients with epilepsy have drug resistance or …

Eslicarbazepine acetate: an update on efficacy and safety in epilepsy

A Verrotti, G Loiacono, A Rossi… - Epilepsy …, 2014 - pubmed.ncbi.nlm.nih.gov
Epilepsy is a common neurological disorder. Despite a broad range of commonly used
antiepileptic drugs, approximately 30% of patients with epilepsy have drug resistance or …

[引用][C] Eslicarbazepine acetate: An update on efficacy and safety in epilepsy

A VERROTTI, G LOIACONO, A ROSSI… - Epilepsy …, 2014 - pascal-francis.inist.fr
Eslicarbazepine acetate: An update on efficacy and safety in epilepsy CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Eslicarbazepine acetate: an update on efficacy and safety in epilepsy.

A Verrotti, G Loiacono, A Rossi, G Zaccara - Epilepsy Research, 2013 - europepmc.org
Epilepsy is a common neurological disorder. Despite a broad range of commonly used
antiepileptic drugs, approximately 30% of patients with epilepsy have drug resistance or …

Eslicarbazepine acetate: An update on efficacy and safety in epilepsy

A Verrotti, G Loiacono, A Rossi, G Zaccara - Epilepsy Research, 2014 - infona.pl
Epilepsy is a common neurological disorder. Despite a broad range of commonly used
antiepileptic drugs, approximately 30% of patients with epilepsy have drug resistance or …

Eslicarbazepine acetate: an update on efficacy and safety in epilepsy

A VERROTTI DI PIANELLA, G Loiacono… - EPILEPSY …, 2014 - research.unipg.it
Epilepsy is a common neurological disorder. Despite a broad range of commonly used
antiepileptic drugs, approximately 30% of patients with epilepsy have drug resistance or …